Search
Meloxicam
go.drugbank.com/drugs/DB00814ApprovedInvestigationalVet approvedIt is a preferential COX-2 inhibitor, purportedly reducing the risk of adverse gastrointestinal tract effects, however, this is a topic of controversy.[A190198,A190201] … [A190189] With a longer half-life than most other NSAIDS, it is a favorable option for those who require once-daily dosing. Meloxicam is available in oral, transdermal, and intravenous formulations.
Mixtures: MELOCAM DUO 7.5/20 MG TABLETAS RECUBIERTAS, OCAM PROTECT 15 MGCategories: COX-2 Inhibitors, Selective Cyclooxygenase 2 Inhibitors (NSAIDs)Cyanocobalamin
go.drugbank.com/drugs/DB00115ApprovedInvestigationalNutraceuticalCyanocobalamin (commonly known as Vitamin B12) is a highly complex, essential vitamin, owing its name to the fact that it contains the mineral, cobalt.
International brands: Cobolin-M, Vitabee 12Mixtures: FOLIDOCE 400 MCG/2 MCG TABLET, 28 ADET, ENJEKSİYONLUK ÇÖZELTİ İÇEREN AMPUL (1 ML VE 2 ML) X 25 AMPULEphedra sinica root
go.drugbank.com/drugs/DB01363ApprovedNutraceuticalThe sale of ephedra-containing supplements intended to increase muscle weight or promote weight loss was banned in the United States in 2004 due to the risk for adverse effects and a lack of evidence for
Synonyms: Cao ma huang root, Ephedra ma-huang rootMixtures: Miller's Formula No. 1Cefpodoxime
go.drugbank.com/drugs/DB01416ApprovedInvestigationalVet approvedCommonly used to treat acute otitis media, pharyngitis, and sinusitis, cefpodoxime proxetil is a prodrug which is absorbed and de-esterified by the intestinal mucosa to Cefpodoxime.
Mixtures: TEXEF PLUS 40 MG/62.5 MG GRANÜL İÇEREN SAŞE, 20 ADET, TEXEF PLUS 50 MG/62.5 MG GRANÜL İÇEREN SAŞE, 20 ADETCategories: Heterocyclic Compounds, 2-RingNuclear factor erythroid 2-related factor 2
go.drugbank.com/bio_entities/BE0010121TargetHumansAlso inhibits both SARS-CoV-2 replication, as well as the replication of several other pathogenic viruses including Herpes Simplex Virus-1 and-2, Vaccinia virus, and Zika virus through a type I interferon … Transcription factor that plays a key role in the response to oxidative stress: binds to antioxidant response (ARE) elements present in the promoter region of many cytoprotective genes, such as phase 2
Polypeptides: Nuclear factor erythroid 2-related factor 2Synonyms: Nrf-2, Nuclear factor, erythroid derived 2, like 2Calfactant
go.drugbank.com/drugs/DB06415ApprovedInvestigationalEach milliliter of calfactant contains 35mg of phospholipids (including 26 mg phosphatidylcholine of which 16 mg is disaturated phosphatidylcholine) and 0.65mg of proteins including surfactant-associated … proteins B and C.
Synonyms: SF-RI 1Products: INFASURF 35 MG/ML INTRATRAKEAL SÜSPANSIYON ,6 ML, INFASURF 35 MG/ML INTRATRAKEAL SÜSPANSIYON,3 MLCefixime
go.drugbank.com/drugs/DB00671ApprovedInvestigationalBacteria possess a cell wall comprising a glycopeptide polymer commonly known as peptidoglycan, which is synthesized and remodelled through the action of a family of enzymes known as "penicillin-binding … [A262995] Third-generation cephalosporins are often a first-line therapy against certain bacterial infections.
Mixtures: INNOCEF PLUS 200/125 MG SAŞE, 20 ADET, INNOCEF PLUS 400/125 MG SAŞE, 20 ADETCategories: Heterocyclic Compounds, 2-RingAnthralin
go.drugbank.com/drugs/DB11157ApprovedAnthralin (1,8‐dihydroxy‐9anthrone, dithranol) is an older anti-psoriatic agent that was first synthesized as a derivative of chrysarobin, obtained from the araroba tree in Brazil over 100 years ago. … It is a main active ingredient in topical skin formulations for the treatment of psoriasis. Various formulations of the drug are available, including solutions, foams, and shampoos [L1979].
Products: Anthraforte 2 Ointment 2%, Anthraforte 1 Ointment 1%Coronavirus Disease 2019 (COVID‑19)
go.drugbank.com/conditions/DBCOND0129755Drugs: Anakinra · Andusomeran · AstraZeneca COVID-19 Vaccine · BNT162B2 Omicron (LP.8.1) · Baricitinib · CX-046684 +26 moreSynonyms: Sars Cov 2, SARS CoV-2Brinzolamide
go.drugbank.com/drugs/DB01194Approved[A2051] Brinzolamide was approved by the FDA in 1998 as a standalone product and in 2013 as a combination product with brimonidine tartrate. … [L35310,L35315] In Europe, it was also approved as a combination product with timolol in 2008.[L35320]
Mixtures: SIMBRINZA EYE DROPS, SUSPENSION 10 MG/ML + 2 MG/ML, SİMBRİNZA 10 MG/ML + 2 MG/ML GÖZ DAMLASI, SÜSPANSİYON, 5 MLCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2A6 Substrates